期刊文献+

聚合物微囊型血液代用品携氧-释氧性能的无损检测方法 被引量:2

A Nondestructive Method to Measure the Oxygen Binding and Releasing Properties of Biodegradable Polymers Microcapsules Intented for Blood Substitutes
暂未订购
导出
摘要 P50是衡量血液代用品携氧-释氧性能的重要指标。本研究借鉴临床脉冲血氧饱和度仪的工作原理,利用近红外光具有强穿透性(能穿透可生物降解聚合物壳材并对包封在壳材内的血红蛋白进行检测),结合氧合血红蛋白和脱氧血红蛋白在近红外光区域有不同的吸收光谱特性,采用自行研制的密封、平衡装置完成对载牛血红蛋白微囊型血液代用品的血氧饱和度和对应氧分压的测定,从而得出氧解离曲线、P50等携氧-释氧指标。该套装置和方法无需破损微囊,过程简单,可实现对聚合物微囊型血液代用品携氧-释氧性能的无损、在位检测。 P50 is an important parameter reflecting the binding and releasing oxygen properties of blood substitutes. In this study, based on the strong penetrating property of near infrared light and the mechanism involved in the pulsatile oxygen meter in clinic as well as on the ability for penetrating biodegradable polymers and detecting bovine hemoglobin encapsulated within the microcapsules, we have made an airproof and equilibrium apparatus to measure oxygen saturation and oxygen partial pressure. Subsequently, we have obtained the oxygen dissociation curve and P50 of the microcapsules loaded bovine hemoglobin in the light of oxyHemoglobin and deoxyHemoglobin with different spectrum in the near infrared region. The above-mentioned apparatus and method are not destructive to the microcapsules, and the process is simple and nondestructive. So it is practical to take in-situ measurements of the oxygen binding and releasing property of biodegradable polymer microcapsules intented for the blood substitute.
机构地区 华东理工大学
出处 《生物医学工程学杂志》 EI CAS CSCD 北大核心 2008年第5期1116-1120,共5页 Journal of Biomedical Engineering
基金 十五"863"纳米专项基金资助项目(2004AA-302050) 上海市科委纳米专项资助项目(0452nm022)
关键词 P50 携氧-释氧 近红外光 载牛血红蛋白微囊 密封平衡装置 无损检测 P50 Binding and releasing oxygen Near infrared light Mirocapsules loaded bovinehemoglobin Airproof and equilibrium apparatus Nondestructive measurement
  • 相关文献

参考文献6

  • 1Winslow RM. Blood substitutes. Advanced Drug Delivery Reviews, 2000; 40:131.
  • 2樊晶,王学谦.人工红细胞及微囊包被血红蛋白的制备与鉴定[J].中国输血杂志,2004,17(2):75-78. 被引量:3
  • 3Mohammed S, Inayat A . Oxygen carriers: a selected review. Transfusion and Apheresis Science, 2006 ; 34 : 25.
  • 4Chang TMS. Future generations of red blood cell substitutes. Journal of Internal Medicine, 2003; 253:527.
  • 5Addison PS, Watson JN. Oxygen saturation determined using a novel wavelet ratio surface. Medical Engineering & Physics. 2005; 27 : 245.
  • 6Giardina B, Amiconi G. Measurement of binding of gaseous and nongaseous ligands to hemoglobins by conventional, Ligend bingding to Hemoglobin. Methods in Enzymology, 1981 ; 76:417.

二级参考文献4

  • 1宋存先.可降解与吸收材料[A].见:俞耀庭主编.生物医用材料[C].天津大学出版社,2000.50-80.
  • 2丁智勇 常烨.纳米助飞人工红血球[EB/OL].Available at http://www.csbt.org.cn/works/bbs/List/2003-03-10/en,.
  • 3樊晶.人工红细胞前瞻性研究进展[J].天津药学,2003,31(5):127-128.
  • 4樊晶,王学谦.人血红蛋白提纯、改造制备人工血液制品的研究[J].天津医药,2003,31(6):346-348. 被引量:2

共引文献2

同被引文献21

  • 1吴玉厚,朱奇,刘殿红,王晶颖,李言秋,周国利,于立权,郭彦.改性血红蛋白携氧载体[J].生物学通报,2005,40(4):17-19. 被引量:2
  • 2王岱娟,牛津梁,张文博,菅晓娟,张文.血红蛋白氧载体研究进展及应用现状[J].中国生化药物杂志,2005,26(6):379-382. 被引量:6
  • 3李涛.人脐带血血红蛋白的分离纯化与病毒灭活工艺研究[D].成都:四川大学,2006.
  • 4Graves PE, Henderson DP, Horstman M J, et al. Enhancing stability and expression of recombinant human hemoglobin in E. coli:Progress in the development of a recombinant HBOC source [J]. Biochim Biophys Acta, 2008,1784 (10) : 1471-1479.
  • 5Yan J B, Wang G Q,Du P,et al. High-level expression and purification of Escherichia coli oligopeptidase B [J]. Protein Expr Purif, 2006,47 (2) : 645- 650.
  • 6Harnois T, Rousselot M,Rogniaux H,et al. High-level production of recombinant arenicola marina globin chains in Escherichia coli:a new generation of blood substitute [J]. Artif Cells Blood Substit Immobil Biotechnol, 2009,37 (3) : 106-116.
  • 7Logan JS,Martin MJ. Transgenie swine as a recombinant production system for human hemogiobin[J]. Meth Enzymol ,1994 , 231: 4 35-439.
  • 8Loeb AL, Mclntoshi LJ,Raj NR,et al. Resuscitation after hemorrhage using recombinant human hemoglohin(rhHbl. 1) in rats effects on nitric oxide and prostanoid systems[J]. Crit Care Med, 1998,26: 1071-1080.
  • 9Fronticelli C, Koehler RC. Design of recombinant hemoglobins for use in transfusion fluids[J]. Crit Care Clin, 2009,25 (2) : 357-371.
  • 10Chang TMS.Red blood cell substitutes[J].Artif Cells Blood S-ubstit Immobil Biotechnol,1996,30(5 & 6):421-437.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部